Marsh & McLennan
MMCNYSEUS Equity
$182.70▼ $2.89 (−1.58%)
Live1h—
24h▼ 1.6%
7d▲ 0.1%
14d▲ 0.1%
30d▲ 0.1%
1y▼ 12.7%
🏦Market Cap
$349B
Large Cap
📈Revenue Growth (YoY)
+33.1%
High Growth
📊Gross Margin
66.2%
High
💵FCF Margin
15.6%
Healthy
⚖️P/S Ratio
10.0x
Elevated
Otter Score
48
Weak
Marsh & McLennan
MMCAnalyst Ratings
Price
$182.70
Total
26
Raised
3
Lowered
6
Avg PT
$199.40
H / L
$257 / $135
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Cantor Fitzgerald | Reiterated | Overweight | 2026-01-14 | $208.00 | +13.80% |
Wells Fargo | Reiterated | Equal Weight | 2026-01-13 | $199.00 | +8.90% |
Barclays | Reiterated | Overweight | 2026-01-08 | $210.00 | +14.90% |
Evercore ISI Group | Reiterated | Outperform | 2026-01-07 | — | — |
JP Morgan | Reiterated | Overweight | 2026-01-07 | $163.00 | −10.80% |
Keefe, Bruyette & Woods | Reiterated | Market Perform | 2026-01-06 | — | — |
Citigroup | Reiterated | Neutral | 2025-12-04 | $190.00 | +4.00% |
B of A Securities | Downgraded | Neutral → Underperform | 2025-11-03 | — | — |
TD Cowen | Reiterated | Hold | 2025-11-03 | — | — |
Goldman Sachs | Upgraded | Sell → Neutral | 2025-10-20 | $199.00 | +8.90% |
UBS | Reiterated | Buy | 2025-10-08 | $257.00 | +40.70% |
Morgan Stanley | Reiterated | Equal Weight | 2025-10-07 | $190.00 | +4.00% |
Jefferies | Reiterated | Hold | 2025-04-11 | $178.00 | −2.60% |
Raymond James | Reiterated | Outperform | 2025-02-06 | $180.00 | −1.50% |
RBC Capital | Upgraded | Sector Perform → Outperform | 2024-12-12 | $200.00 | +9.50% |
BMO Capital | Reiterated | Market Perform | 2024-10-22 | $228.00 | +24.80% |
Roth MKM | Reiterated | Neutral | 2024-10-18 | — | — |
Piper Sandler | Downgraded | Overweight → Neutral | 2024-04-17 | $211.00 | +15.50% |
Credit Suisse | Reiterated | Neutral | 2023-01-30 | $157.00 | −14.10% |
Atlantic Equities | Downgraded | Overweight → Neutral | 2022-11-08 | $185.00 | +1.30% |
MKM Partners | Reiterated | Neutral | 2020-05-01 | — | — |
CFRA | Upgraded | Hold → Buy | 2020-04-30 | — | — |
Deutsche Bank | Downgraded | Buy → Hold | 2017-10-04 | $135.00 | −26.10% |
Macquarie | Downgraded | Outperform → Neutral | 2014-09-25 | — | — |
Nomura | Reiterated | Neutral | 2014-03-12 | — | — |
Miller Tabak | Downgraded | Buy → Hold | 2013-10-04 | — | — |
Institution
Cantor Fitzgerald
Reiterated · Overweight · 2026-01-14
$208.00
+13.80%
Wells Fargo
Reiterated · Equal Weight · 2026-01-13
$199.00
+8.90%
Barclays
Reiterated · Overweight · 2026-01-08
$210.00
+14.90%
Evercore ISI Group
Reiterated · Outperform · 2026-01-07
—
—
JP Morgan
Reiterated · Overweight · 2026-01-07
$163.00
−10.80%
Keefe, Bruyette & Woods
Reiterated · Market Perform · 2026-01-06
—
—
Citigroup
Reiterated · Neutral · 2025-12-04
$190.00
+4.00%
B of A Securities
Downgraded · Neutral → Underperform · 2025-11-03
—
—
TD Cowen
Reiterated · Hold · 2025-11-03
—
—
Goldman Sachs
Upgraded · Sell → Neutral · 2025-10-20
$199.00
+8.90%
UBS
Reiterated · Buy · 2025-10-08
$257.00
+40.70%
Morgan Stanley
Reiterated · Equal Weight · 2025-10-07
$190.00
+4.00%
Jefferies
Reiterated · Hold · 2025-04-11
$178.00
−2.60%
Raymond James
Reiterated · Outperform · 2025-02-06
$180.00
−1.50%
RBC Capital
Upgraded · Sector Perform → Outperform · 2024-12-12
$200.00
+9.50%
BMO Capital
Reiterated · Market Perform · 2024-10-22
$228.00
+24.80%
Roth MKM
Reiterated · Neutral · 2024-10-18
—
—
Piper Sandler
Downgraded · Overweight → Neutral · 2024-04-17
$211.00
+15.50%
Credit Suisse
Reiterated · Neutral · 2023-01-30
$157.00
−14.10%
Atlantic Equities
Downgraded · Overweight → Neutral · 2022-11-08
$185.00
+1.30%
MKM Partners
Reiterated · Neutral · 2020-05-01
—
—
CFRA
Upgraded · Hold → Buy · 2020-04-30
—
—
Deutsche Bank
Downgraded · Buy → Hold · 2017-10-04
$135.00
−26.10%
Macquarie
Downgraded · Outperform → Neutral · 2014-09-25
—
—
Nomura
Reiterated · Neutral · 2014-03-12
—
—
Miller Tabak
Downgraded · Buy → Hold · 2013-10-04
—
—
One row per institution · price target from the firm's latest published target